Valuation: ArcticZymes Technologies ASA

Market Cap 1.03B 107M 93.83M 87.17M 80.17M 150M 10.33B 153M 1.04B 407M 5.04B 401M 392M 17.48B P/E 2026 *
57.4x
P/E 2027 * 32x
Enterprise Value 749M 77.81M 68.44M 63.58M 58.47M 110M 7.54B 112M 760M 297M 3.68B 292M 286M 12.75B EV / Sales 2026 *
5.47x
EV / Sales 2027 * 4.42x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 week+5.24%
1 month-0.99%
3 months-2.90%
6 months-10.67%
Current year-2.43%
1 week 18.4
Extreme 18.4
20.2
1 month 18.35
Extreme 18.35
20.9
Current year 18.3
Extreme 18.3
26.6
1 year 17.7
Extreme 17.7
31.4
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
109
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 2023-09-17
Director of Finance/CFO 51 2014-09-30
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 2024-06-25
Director/Board Member 62 2024-06-25
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
8/14/25 Buy

Director

2,852 0.0056%
6/4/25 Buy

Chief Operating Officer

3,400 0.0067%
5/14/25 Fiscal year

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.24%+18.58%-47.72% 107M
+1.97%+1.43%+48.44%+156.66% 1,057B
+1.42%+3.72%+53.32%+52.34% 624B
+1.43%+0.99%+34.83%+78.74% 454B
+5.14%+5.40%+33.75%+27.28% 341B
+1.85%+3.57%+37.09%+39.87% 297B
-0.11%+0.48%+18.87%+17.81% 262B
+0.25%-4.62%-27.66%-42.25% 215B
+1.49%-0.02%+20.14%+58.21% 201B
+0.40%-3.99%+15.23%+62.28% 162B
Average +1.38%+1.22%+25.26%+40.32% 361.41B
Weighted average by Cap. +1.75%+1.57%+35.51%+75.42%

Financials

2026 *2027 *
Net sales 137M 14.23M 12.52M 11.63M 10.69M 20.05M 1.38B 20.41M 139M 54.23M 672M 53.42M 52.27M 2.33B 162M 16.84M 14.81M 13.76M 12.66M 23.73M 1.63B 24.16M 165M 64.18M 796M 63.23M 61.86M 2.76B
Net income 18.12M 1.88M 1.66M 1.54M 1.42M 2.65M 182M 2.7M 18.4M 7.18M 88.96M 7.07M 6.92M 309M 32.59M 3.39M 2.98M 2.77M 2.55M 4.77M 328M 4.86M 33.1M 12.91M 160M 12.72M 12.44M 555M
Net Debt -278M -28.88M -25.4M -23.59M -21.7M -40.69M -2.8B -41.42M -282M -110M -1.36B -108M -106M -4.73B -310M -32.26M -28.37M -26.35M -24.24M -45.46M -3.12B -46.27M -315M -123M -1.52B -121M -118M -5.29B
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
26-07-23 NOK 20.10 +1.52% 10,725
26-07-22 NOK 19.80 +1.28% 8,269
26-07-21 NOK 19.55 +4.83% 6,122
26-07-20 NOK 18.65 -1.06% 15,173
26-07-17 NOK 18.85 -1.31% 13,735
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
20.10NOK
Average target price
31.00NOK
Spread / Average Target
+54.23%

Quarterly revenue - Rate of surprise